Manhattan Scientifics, Inc. announced earnings results for the first quarter ended March 31, 2019. For the first quarter, the company announced operating loss was USD 221,000 compared to USD 429,000 a year ago. Net loss was USD 436,000 compared to USD 2.828 million a year ago. Basic eps - continuing operations was USD 0 compared to basic loss per share from continuing operations of USD 0.01 a year ago.